Artios Pharma Ltd

Quick facts

Phase 2 pipeline

• ART0380 · Oncology
  ART0380 is a DNA-protein crosslink (DPC) repair inhibitor that enhances the activity of DNA damaging agents by preventing cellular repair of crosslinks.

Phase 1 pipeline

• ART4215
• ART6043

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Artios Pharma Ltd portfolio CI brief
• Artios Pharma Ltd pipeline updates RSS